Novartis Ag (NVS) Capital Expenditures (2009 - 2026)
Novartis Ag (NVS) reported Capital Expenditures of $321 million for Q2 2026, down 3.0% from $331 million a year earlier.
Novartis Ag (NVS) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novartis Ag's Capital Expenditures came in at -$988 million; for FY2025, it came in at $1.55 billion, up 13.3% from FY2024.
- Capital Expenditures has increased for three consecutive years, with a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $1.37 billion in FY2024 (+28.9%), $1.06 billion in FY2023 (+15.7%), $916 million in FY2022 (-14.1%) and $1.07 billion in FY2021 (-16.4%).
- Five-year quarterly Capital Expenditures spans a low of -$609 million in Q4 2025 and a high of $331 million in Q2 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$346 million (Q1 2026), -$609 million (Q4 2025) and -$354 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -39,045.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 3.18 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 1.36 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 301.00 Mn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 1.04 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 573.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 321.00 Mn |
| Mar 31, 2026 | -346.00 Mn |
| Dec 31, 2025 | -609.00 Mn |
| Sep 30, 2025 | -354.00 Mn |
| Jun 30, 2025 | 331.00 Mn |
| Mar 31, 2025 | -254.00 Mn |
| Dec 31, 2024 | -558.00 Mn |
| Sep 30, 2024 | -321.00 Mn |
| Jun 30, 2024 | 260.00 Mn |
| Mar 31, 2024 | -227.00 Mn |
| Dec 31, 2023 | -406.00 Mn |
| Sep 30, 2023 | -261.00 Mn |
| Jun 30, 2023 | 225.00 Mn |
| Mar 31, 2023 | -168.00 Mn |
| Dec 31, 2022 | -306.00 Mn |
| Sep 30, 2022 | -221.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | -257.00 Mn |
| Dec 31, 2021 | -460.00 Mn |
| Sep 30, 2021 | -351.00 Mn |
Novartis Ag Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();